Patent 11834654 was granted and assigned to Kite Pharma, Inc. on December, 2023 by the United States Patent and Trademark Office.
Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GGGS (SEQ ID NO: 1), GGGGS (SEQ ID NO: 46) and related sequences are provided. The antigen binding molecules may be used in the methods provided herein.